| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872769 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 10 Pages |
Abstract
Although a positive mid- or postchemotherapy gallium scan was an adverse prognostic factor for OS, FFTF, and PFS, continued treatment with conventional-dose therapy may be adequate in selected patients with positive scans.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Andrea K. M.D., M.P.H., M.V.Patricia Sc.D., Barbara B.A., Annick M.D., Mary Ann M.D., Ph.D., David C. M.D., Peter M. M.D.,